Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (171-180 of 361) with videos related to

Pageof 37
Sort By:
Acta Clinica Belgica|May 5, 2020
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literatureAnke Delie, Anke Verlinden, Karolien Beel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Cancer|April 1, 2018
Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMTTomasz Czerw, Myriam Labopin, Sebastian Giebel, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG ConditioningMuriel Hannon, Yves Beguin, Grégory Ehx, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 25, 2017
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in SpainSantiago Grau, Jose Ramon Azanza, Isabel Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2007
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working PartyChristoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Bone Marrow Transplantation|April 18, 2018
Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemiaGiorgia Battipaglia, Annalisa Ruggeri, Myriam Labopin, et al.
British Journal of Haematology|February 6, 2020
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remissionMarina Díaz-Beyá, Myriam Labopin, Johan Maertens, et al.
The Lancet. Infectious Diseases|May 31, 2022
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in LeukaemiaAnne Bergeron, Malgorzata Mikulska, Julien De Greef, et al.
Pageof 37

Showing results (171-180 of 361) with videos related to

Sort By:
Pageof 37
Acta Clinica Belgica|May 5, 2020
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literatureAnke Delie, Anke Verlinden, Karolien Beel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Cancer|April 1, 2018
Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMTTomasz Czerw, Myriam Labopin, Sebastian Giebel, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG ConditioningMuriel Hannon, Yves Beguin, Grégory Ehx, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 25, 2017
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in SpainSantiago Grau, Jose Ramon Azanza, Isabel Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2007
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working PartyChristoph Schmid, Myriam Labopin, Arnon Nagler, et al.
Bone Marrow Transplantation|April 18, 2018
Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemiaGiorgia Battipaglia, Annalisa Ruggeri, Myriam Labopin, et al.
British Journal of Haematology|February 6, 2020
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remissionMarina Díaz-Beyá, Myriam Labopin, Johan Maertens, et al.
The Lancet. Infectious Diseases|May 31, 2022
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in LeukaemiaAnne Bergeron, Malgorzata Mikulska, Julien De Greef, et al.
Pageof 37